All Stories

  1. How type 2 diabetes and COPD affect each other: a review of mechanisms and patient management
  2. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.
  3. Kounis Syndrome Features in Special Populations
  4. Impact of older age on prognosis in hypersensitivity pneumonitis: A systematic review and meta‑analysis
  5. COPD and kidney disease: not so far apart?
  6. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  7. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  8. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  9. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  10. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  11. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  12. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  13. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  14. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  15. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  16. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  17. Burden of ophthalmologic disorders in obstructive sleep apnea
  18. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  19. Fungal allergy - features of molecular diagnosis
  20. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  21. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  22. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  23. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  24. The impact of comorbidities on chronic obstructive pulmonary disease
  25. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  26. Comparative analysis of clinical characteristics of gout patients
  27. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  28. Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
  29. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  30. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  31. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  32. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  33. Diagnostic tools in respiratory medicine (Review)
  34. COPD and Depression—The Vicious Mental Cycle
  35. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  36. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  37. Challenges of Pediatric Tuberculosis Under Current Conditions
  38. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  39. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  40. Assessment of comorbidities in COPD patients by chest HRCT
  41. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  42. Sarcoidosis and cancer - a diagnostic dilema
  43. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  44. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  45. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  46. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  47. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  48. Editorial: Treatment of comorbidities of asthma and its safety
  49. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  50. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  51. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  52. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  53. Promising treatment biomarkers in asthma
  54. Complications of tracheobronchial foreign body aspiration in children
  55. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  56. The Burden of Comorbidities in Obstructive Sleep Apnea
  57. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  58. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  59. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  60. Updates in screening for tuberculosis. Review of guidelines
  61. Diagnostic challenges of a rare disease with an unusual presentation
  62. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  63. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  64. COPD and Diabetes Mellitus: Down the Rabbit Hole
  65. Scientists Against War: A Plea to World Leaders for Better Governance
  66. COPD and comorbidities in the Republic of Moldova
  67. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  68. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  69. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  70. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  71. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  72. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  73. Asthma-COPD Overlap: A more Simplistic Approach
  74. Chronic obstructive disease and comorbidities (literature review)
  75. Current Approaches to Asthma In 2021
  76. A rare case of intrathymic epidermoid cyst
  77. Asthma and stroke: a narrative review
  78. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  79. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  80. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  81. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  82. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  83. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  84. Current Approaches to COPD in 2019
  85. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  86. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  87. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  88. Identification of clinical phenotypes using cluster analyses in COPD patients
  89. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  90. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  91. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  92. COPD and Stroke
  93. Health-related quality of life in different phenotypes of COPD
  94. Assessment of health-related quality of life in different phenotypes of COPD
  95. Bode index in different phenotypes of COPD
  96. To sleep, or not to sleep?
  97. ACOS: current evidence and future research directions
  98. Phenotyping Before Starting Treatment in COPD?
  99. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  100. Exercise-Induced Pulmonary Edema in Athletes
  101. Editorial: "COPD: More than a Moving Target!"
  102. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  103. Prevalence and burden of comorbidities in COPD
  104. Meet Our Assistant Editor
  105. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  106. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  107. Health-Related Quality of Life in Patients with COPD
  108. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  109. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  110. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  111. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  112. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  113. Management of Stable COPD: An Update
  114. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  115. Defining COPD
  116. Imaging for diagnosis and management of tuberculosis